Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · IEX Real-Time Price · USD
6.82
+1.84 (36.95%)
At close: Apr 18, 2024, 4:00 PM
6.72
-0.10 (-1.47%)
After-hours: Apr 18, 2024, 7:59 PM EDT

Benitec Biopharma Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.
Year 2023202220212020201920182017201620152014
Net Income
-19.56-18.21-13.88-8.272.61-8.11-3.97-17.27-8.02-4.91
Depreciation & Amortization
0.380.390.420.370.1600000
Share-Based Compensation
0.450.870.630.240.6700000
Other Operating Activities
0.721.05-0.010.131.351.29-1.823.191.27-1.56
Operating Cash Flow
-18.01-15.9-12.83-7.544.79-6.83-5.79-14.08-6.76-6.46
Capital Expenditures
-0-0.01-0.22-0.09-0.4-0.06-0.12-0.24-0.35-0.02
Change in Investments
000000-0.09000
Other Investing Activities
------0.05----
Investing Cash Flow
-0-0.01-0.22-0.09-0.4-0.1-0.21-0.24-0.35-0.02
Share Issuance / Repurchase
17.88025.752.2506.155.6313.570.2727.24
Other Financing Activities
-1.87--3.23-0.48--0.22-0.09-1.36-0.23-
Financing Cash Flow
16.02022.521.7705.935.5312.20.0427.24
Exchange Rate Effect
0.410.20.5-0.06-0.550.1-0.13-0.360.4-0
Net Cash Flow
-1.59-15.719.97-5.864.39-1-0.46-2.12-7.0720.75
Free Cash Flow
-18.01-15.91-13.05-7.634.39-6.88-5.91-14.32-7.11-6.48
Free Cash Flow Margin
-24017.33%-21797.26%-22123.73%-7479.41%35.99%-221.16%-78.18%-506.91%-256.72%-1555.69%
Free Cash Flow Per Share
-13.00-33.10-51.66-127.0087.11-114.08-137.06-420.25-208.53-
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).